Overview
- INJ rallied roughly 25–30% in 24 hours and has gained more than 30% from its breakout, with prices trading around $9 to $9.35 on Friday as volume and derivatives open interest rose.
- Injective has been strengthening its U.S. regulatory footing by securing SEC transfer‑agent registration and saying CEO Eric Chen held talks with White House, SEC and CFTC officials about tokenization.
- Gulf Labs, part of Thailand’s GULF Group, has begun operating as an institutional validator on Injective to support transaction validation, network security and tokenization pilots.
- Injective reports a leading revenue‑to‑fully‑diluted‑value ratio and routes on‑chain revenue into a monthly Community BuyBack that reduces supply, while Santiment data shows exchange‑held INJ fell to about 872,500 tokens.
- Traders are watching technical projections that put a target near $14, the progress of multiple proposed staked‑INJ ETF filings that still require SEC approval, and whether higher trading volume holds after this initial spike.